KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) FCF Margin (2016 - 2025)

Historic FCF Margin for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to 27.81%.

  • Globus Medical's FCF Margin rose 19700.0% to 27.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.93%, marking a year-over-year increase of 90700.0%. This contributed to the annual value of 16.08% for FY2024, which is 55500.0% up from last year.
  • Globus Medical's FCF Margin amounted to 27.81% in Q3 2025, which was up 19700.0% from 4.2% recorded in Q2 2025.
  • Globus Medical's 5-year FCF Margin high stood at 29.4% for Q4 2024, and its period low was 3.93% during Q1 2024.
  • Over the past 5 years, Globus Medical's median FCF Margin value was 13.49% (recorded in 2023), while the average stood at 15.34%.
  • In the last 5 years, Globus Medical's FCF Margin crashed by -176500bps in 2022 and then soared by 196800bps in 2025.
  • Over the past 5 years, Globus Medical's FCF Margin (Quarter) stood at 23.68% in 2021, then decreased by -30bps to 16.62% in 2022, then fell by -20bps to 13.27% in 2023, then surged by 122bps to 29.4% in 2024, then fell by -5bps to 27.81% in 2025.
  • Its FCF Margin was 27.81% in Q3 2025, compared to 4.2% in Q2 2025 and 23.61% in Q1 2025.